Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer

被引：0
|
作者：
Aung, Wint Yan
Lee, Chung-Shien
Morales, Jaclyn
Kohn, Nina
Rahman, Husneara
Seetharamu, Nagashree
机构：
[1] Northwell Hlth, Manhasset, NY USA
[2] Northwell Hlth Canc Inst, New Hyde Pk, NY USA
[3] Feinstein Inst Med Res, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1574 - S1575
  • [42] Efficacy and safety of immune checkpoint inhibitors for patients with prostate cancer: a systematic review and meta-analysis
    Noori, Maryam
    Azizi, Shadi
    Mahjoubfar, Aref
    Varaki, Farhan Abbasi
    Fayyaz, Farimah
    Mousavian, Amir-Hossein
    Bashash, Davood
    Parizi, Mehdi Kardoust
    Kasaeian, Amir
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Endocrine Dysfunction of Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yang, F.
    Lin, L.
    Chen, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [44] Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
    Lee, P. W. P.
    Krishnan, N.
    Boldt, G.
    Lakkunarajah, S.
    Blanchette, P.
    Raphael, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1076 - S1076
  • [45] Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study
    Zhang, Dongming
    Shi, Yuequan
    Liu, Xiaoyan
    Liu, Jia
    Xu, Yan
    Zhao, Jing
    Zhong, Wei
    Hakozaki, Taiki
    Provencio, Mariano
    Horita, Nobuyuki
    Fukuda, Nobuhiko
    Chen, Minjiang
    Wang, Mengzhao
    Kasmann, Lukas
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (07) : 1420 - 1433
  • [46] Fatal Adverse Events Associated With Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yu, Xiaolin
    Zhang, Xiaomei
    Yao, Ting
    Zhang, Ye
    Zhang, Yanxia
    FRONTIERS IN MEDICINE, 2021, 8
  • [47] Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis
    Yang, Kaili
    Li, Jiarui
    Bai, Chunmei
    Sun, Zhao
    Zhao, Lin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] The efficacy and safety of immune checkpoint inhibitor in patients with relapsed small-cell lung cancer: A systematic review and meta-analysis
    Xu, Yulian
    Chen, Mingxian
    Ding, Yanpeng
    Guo, Feng
    Chen, Min
    Lu, Tianzhen
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (04) : 421 - 429
  • [49] Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors: A Meta-Analysis
    Lin, Lanlan
    Yang, Fan
    Lin, Guofu
    Chen, Xiangqi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 210 - 218
  • [50] Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: A network meta-analysis
    Zhang, Lin
    Chen, Wei
    Wei, Hongtao
    Yu, Junxian
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (04):
12345